473 related articles for article (PubMed ID: 20207458)
1. A randomized double-blind controlled trial of taurolidine-citrate catheter locks for the prevention of bacteremia in patients treated with hemodialysis.
Solomon LR; Cheesbrough JS; Ebah L; Al-Sayed T; Heap M; Millband N; Waterhouse D; Mitra S; Curry A; Saxena R; Bhat R; Schulz M; Diggle P
Am J Kidney Dis; 2010 Jun; 55(6):1060-8. PubMed ID: 20207458
[TBL] [Abstract][Full Text] [Related]
2. Observational study of need for thrombolytic therapy and incidence of bacteremia using taurolidine-citrate-heparin, taurolidine-citrate and heparin catheter locks in patients treated with hemodialysis.
Solomon LR; Cheesbrough JS; Bhargava R; Mitsides N; Heap M; Green G; Diggle P
Semin Dial; 2012; 25(2):233-8. PubMed ID: 21916999
[TBL] [Abstract][Full Text] [Related]
3. Approaches to prolong the use of uncuffed hemodialysis catheters: results of a randomized trial.
Filiopoulos V; Hadjiyannakos D; Koutis I; Trompouki S; Micha T; Lazarou D; Vlassopoulos D
Am J Nephrol; 2011; 33(3):260-8. PubMed ID: 21372561
[TBL] [Abstract][Full Text] [Related]
4. Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution.
Betjes MG; van Agteren M
Nephrol Dial Transplant; 2004 Jun; 19(6):1546-51. PubMed ID: 14993498
[TBL] [Abstract][Full Text] [Related]
5. Prophylaxis against dialysis catheter-related bacteremia with a novel antimicrobial lock solution.
Allon M
Clin Infect Dis; 2003 Jun; 36(12):1539-44. PubMed ID: 12802753
[TBL] [Abstract][Full Text] [Related]
6. A randomized trial comparing gentamicin/citrate and heparin locks for central venous catheters in maintenance hemodialysis patients.
Moran J; Sun S; Khababa I; Pedan A; Doss S; Schiller B
Am J Kidney Dis; 2012 Jan; 59(1):102-7. PubMed ID: 22088576
[TBL] [Abstract][Full Text] [Related]
7. Preventing catheter-related bacteremia with taurolidine-citrate catheter locks: a systematic review and meta-analysis.
Liu H; Liu H; Deng J; Chen L; Yuan L; Wu Y
Blood Purif; 2014; 37(3):179-87. PubMed ID: 24777144
[TBL] [Abstract][Full Text] [Related]
8. Sodium citrate versus heparin catheter locks for cuffed central venous catheters: a single-center randomized controlled trial.
Power A; Duncan N; Singh SK; Brown W; Dalby E; Edwards C; Lynch K; Prout V; Cairns T; Griffith M; McLean A; Palmer A; Taube D
Am J Kidney Dis; 2009 Jun; 53(6):1034-41. PubMed ID: 19394731
[TBL] [Abstract][Full Text] [Related]
9. Randomized, clinical trial comparison of trisodium citrate 30% and heparin as catheter-locking solution in hemodialysis patients.
Weijmer MC; van den Dorpel MA; Van de Ven PJ; ter Wee PM; van Geelen JA; Groeneveld JO; van Jaarsveld BC; Koopmans MG; le Poole CY; Schrander-Van der Meer AM; Siegert CE; Stas KJ;
J Am Soc Nephrol; 2005 Sep; 16(9):2769-77. PubMed ID: 16033861
[TBL] [Abstract][Full Text] [Related]
10. Randomized controlled trial of taurolidine citrate versus heparin as catheter lock solution in paediatric patients with haematological malignancies.
Dümichen MJ; Seeger K; Lode HN; Kühl JS; Ebell W; Degenhardt P; Singer M; Geffers C; Querfeld U
J Hosp Infect; 2012 Apr; 80(4):304-9. PubMed ID: 22342714
[TBL] [Abstract][Full Text] [Related]
11. Taurolidine-based catheter lock regimen significantly reduces overall costs, infection, and dysfunction rates of tunneled hemodialysis catheters.
Winnicki W; Herkner H; Lorenz M; Handisurya A; Kikić Ž; Bielesz B; Schairer B; Reiter T; Eskandary F; Sunder-Plassmann G; Sengoelge G
Kidney Int; 2018 Mar; 93(3):753-760. PubMed ID: 28890326
[TBL] [Abstract][Full Text] [Related]
12. A new haemodialysis catheter-locking agent reduces infections in haemodialysis patients.
Taylor C; Cahill J; Gerrish M; Little J
J Ren Care; 2008 Sep; 34(3):116-20. PubMed ID: 18786077
[TBL] [Abstract][Full Text] [Related]
13. A Taurolidine-Citrate-Heparin Lock Solution Effectively Eradicates Pathogens From the Catheter Biofilm in Hemodialysis Patients.
Zwiech R; Adelt M; Chrul S
Am J Ther; 2016; 23(2):e363-8. PubMed ID: 23665885
[TBL] [Abstract][Full Text] [Related]
14. [Catheter lock solution--taurolock for prevention of catheter-related bacteremia in hemodialysis patients].
Geron R; Tanchilevski O; Kristal B
Harefuah; 2006 Dec; 145(12):881-4, 943. PubMed ID: 17220025
[TBL] [Abstract][Full Text] [Related]
15. Prevention of tunneled cuffed hemodialysis catheter-related dysfunction and bacteremia by a neutral-valve closed-system connector: a single-center randomized controlled trial.
Bonkain F; Racapé J; Goncalvez I; Moerman M; Denis O; Gammar N; Gastaldello K; Nortier JL
Am J Kidney Dis; 2013 Mar; 61(3):459-65. PubMed ID: 23228946
[TBL] [Abstract][Full Text] [Related]
16. The impact of catheter-restricted filling with cefotaxime and heparin on the lifespan of temporary hemodialysis catheters: a case controlled study.
Saxena AK; Panhotra BR
J Nephrol; 2005; 18(6):755-63. PubMed ID: 16358235
[TBL] [Abstract][Full Text] [Related]
17. Taurolidine-citrate-heparin lock reduces catheter-related bloodstream infections in intestinal failure patients dependent on home parenteral support: a randomized, placebo-controlled trial.
Tribler S; Brandt CF; Petersen AH; Petersen JH; Fuglsang KA; Staun M; Broebech P; Moser CE; Jeppesen PB
Am J Clin Nutr; 2017 Sep; 106(3):839-848. PubMed ID: 28793993
[No Abstract] [Full Text] [Related]
18. Taurolidine-citrate-heparin catheter lock solution reduces staphylococcal bacteraemia rates in haemodialysis patients.
Murray EC; Deighan C; Geddes C; Thomson PC
QJM; 2014 Dec; 107(12):995-1000. PubMed ID: 24939191
[TBL] [Abstract][Full Text] [Related]
19. Linezolid versus vancomycin antibiotic lock solution for the prevention of nontunneled catheter-related blood stream infections in hemodialysis patients: a prospective randomized study.
Sofroniadou S; Revela I; Smirloglou D; Makriniotou I; Zerbala S; Kouloubinis A; Samonis G; Iatrou C
Semin Dial; 2012 May; 25(3):344-50. PubMed ID: 22074188
[TBL] [Abstract][Full Text] [Related]
20. Cefazolin-gentamicin versus taurolidine-citrate for the prevention of infection in tunneled central catheters in hemodialysis patients: A quasi-experimental trial.
Bueloni TNV; Marchi D; Caetano C; de Souza Cavalcante R; Mendes Amaral ML; Ponce D
Int J Infect Dis; 2019 Aug; 85():16-21. PubMed ID: 31102823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
